Beyond Muscle Weakness: Unraveling Endocrine and Metabolic Dysfunctions in Duchenne Muscular Dystrophy, a Narrative Review
<b>Background:</b> Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular disorder caused by mutations in the <i>DMD</i> gene, leading to progressive muscle degeneration, loss of ambulation, and multi-systemic complications. Beyond its impact on mobility, DMD is...
Saved in:
| Main Authors: | Giuseppe Cannalire, Giacomo Biasucci, Vanessa Sambati, Tommaso Toschetti, Arianna Maria Bellani, Anna-Mariia Shulhai, Federica Casadei, Erika Rita Di Bari, Francesca Ferraboschi, Cecilia Parenti, Maria Carmela Pera, Susanna Esposito, Maria Elisabeth Street |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1613 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications
by: Despoina Galetaki, et al.
Published: (2024-09-01) -
Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01) -
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991-04-01) -
Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review
by: Anna Teresa Michalska, et al.
Published: (2025-07-01)